The objective of this study is to provide evidence for its fermentability of a dietary fiber and to collect information regarding potential health opportunities for glucose control as well as tolerability when being consumed over 7 days.

This study is designed as a randomized, 2-arm, treatment-controlled, within-subjects, 8-hour postprandial crossover study, utilizing a multiple sampling paradigm to evaluate fermentability and potential health opportunities for glucose control of a dietary fiber (FCHO) in healthy non-obese men and women. The study will include 2 - 8 h assessments following consumption of the FCHO drink or a placebo drink and will follow with a 7 day feeding period to assess tolerability.

Inclusion Criteria:

• 18 years of age or older
• BMI between 18.5 and 29.9 kg/m2, inclusive
• No clinical evidence of cardiovascular, metabolic, respiratory, renal, gastrointestinal, or hepatic disease
• No diabetes
• No Gastrointestinal issues

Exclusion Criteria:

• Pregnant and/or lactating or planning for pregnancy
• Allergies or intolerances to foods consumed in the study Fasting blood glucose > 125 mg/dL.
• Vegetarian
• Taking over the counter fiber supplements or other supplements that may interfere with the study procedures or endpoints
• Taking actively probiotics or purposely taking/ subscribing to a diet high in prebiotics.
• Taking prescription medications that may interfere with study procedures or endpoints (eg., antibiotics)
• Subjects with unusual dietary habits (e.g. pica)
• Actively losing weight or trying to lose weight (unstable body weight fluctuations of > 5 kg in a 60 day period)
• Excessive exercisers or trained athletes
• Addicted to drugs and/or alcohol
• Medically documented psychiatric or neurological disturbances
• Smokers (past smokers may be allowed if cessation is > 2 years)